Biotech Kate Sheridan STAT Plus: ‘Every man and his dog’ does cell therapy. Vor’s new CEO says the company wants to be different
Politics Nicholas Florko STAT Plus: As CAR-T changes lives, Medicare’s top official explains why it’s proving so hard to pay for it
Biotech Meghana Keshavan STAT Plus: Q&A: Repurposing existing drugs for new uses in cancer — for no profit